ANTI-TSH RECEPTOR ANTIBODY (TRAb) - ANVISA Registration 80254180468
Access comprehensive regulatory information for ANTI-TSH RECEPTOR ANTIBODY (TRAb) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180468 and manufactured by PHADIA AB. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including MEDIPAN, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80254180468
25351380567202485
04930429000139
Company Information
Dates and Status
Sep 02, 2024
VIGENTE
09/18/2025 19:00:01
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb)
Famรญlia ARCHITECT Trab
ABBOTT IRELAND DIAGNOSTICS DIVISION
80146502336
Aug 12, 2021
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb)
Famรญlia Alinity i Trab
ABBOTT IRELAND DIAGNOSTICS DIVISION
80146502337
Aug 12, 2021
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb)
iFlash-anti-TSHR
SHENZHEN YHLO BIOTECH CO., LTD.
80867150057
Dec 23, 2020
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb)
Famรญlia BRAHMS TRAK Human KRYPTOR
B-R-A-H-M-S GMBH
80254180363
Jul 27, 2020
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb)
Famรญlia Elecsys Anti-TSHR
ROCHE DIAGNOSTICS GMBH
10287411446
Oct 07, 2019

